Skip to main content

Table 4 Stratified analysis of the interaction between the HDL-C/apoA-I ratio and FT3 level

From: The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk

Variable

HDL-C/apoA-I

> 0.89 mmol/g

≤ 0.89 mmol/g

OR (95% CI)

P

OR (95% CI)

P

FT3 > 4.5 pmol/L *age ≥ 55 years

  

1.613 (1.150–2.262)

0.006

FT3 > 4.5 pmol/L *age < 55 years

  

1.445 (0.722–2.892)

0.298

FT3 ≤ 4.5 pmol/L*age5 ≥ 55 years

1.805 (1.298–2.511)

< 0.001

2.231 (1.534–3.245)

0.002

FT3 ≤ 4.5 pmol/L *age < 55 years

1.049 (0.461–2.388)

0.910

5.506 (1.741–17.408)

0.004

FT3 > 4.5 pmol/L *male

  

1.748 (1.199–2.547)

0.004

FT3 > 4.5 pmol/L *female

  

1.129 (0.661–1.927)

0.658

FT3 ≤ 4.5 pmol/L*male

1.543 (1.041–2.287)

0.031

2.578 (1.591–4.177)

< 0.001

FT3 ≤ 4.5 pmol/L*female

2.198 (1.337–3.614)

0.002

2.803 (1.633–4.809)

< 0.001

FT3 > 4.5 pmol/L *BMI ≥ 28 kg/m2

  

2.966 (1.374–6.405)

0.006

FT3 > 4.5 pmol/L *BMI28 < kg/m2

  

1.381 (0.981–1.944)

0.065

FT3 ≤ 4.5 pmol/L* BMI ≥ 28 kg/m2

3.062 (1.235–7.592)

0.016

2.923 (1.223–6.988)

0.016

FT3 ≤ 4.5 pmol/L* BMI < 28 kg/m2

1.469 (1.049–2.059)

0.025

2.333 (1.561–3.489)

< 0.001

FT3 > 4.5 pmol/L*EH (yes)

  

1.420 (0.974–2.270)

0.069

FT3 > 4.5 pmol/L*EH (no)

  

1.790 (1.063–3.014)

0.029

FT3 ≤ 4.5 pmol/L*EH (yes)

1.555 (1.056–2.292)

0.025

2.446 (1.570–3.813)

< 0.001

FT3 ≤ 4.5 pmol/L*EH (no)

1.850 (1.118–3.061)

0.017

2.273 (1.252–4.125)

0.007

FT3 > 4.5 pmol/L* DM (yes)

  

1.683 (0.797–3.552)

0.172

FT3 > 4.5 pmol/L* DM (no)

  

1.469 (1.049–2.056)

0.025

FT3 ≤ 4.5 pmol/L* DM (yes)

1.476 (0.697–3.127)

0.309

2.184 (0.994–4.796)

0.052

FT3 ≤ 4.5 pmol/L* DM (no)

1.663 (1.186–2.332)

0.003

2.229 (1.493–3.328)

< 0.001

  1. BMI Body mass index, EH essential hypertension, DM diabetic mellitus, HDL-C high-density lipoprotein cholesterol, apoA-I apolipoprotein A-I, FT3 free triiodothyronine
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us